Tertiary Prevention of Child Sexual Abuse

January 5, 2026 updated by: University of Minnesota

Mobilizing Evidence Into Tertiary Prevention of Child Sexual Abuse: A Pilot Study

This is a feasibility study designed to inform the development of a multinational study of the effectiveness of a tertiary prevention program for child sexual abuse. This study targets adult men who have engaged in child sexual abuse, and will be implemented within the Minnesota Department of Corrections. Data will include measures of the implementation process, short-terms changes in criminogenic factors, and staff and participant factors that could influence outcomes.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male
  • 18 or older
  • Serving time in MnDOC facilities for Criminal Sexual Conduct in the first, second, or third degree, whose victims were less than 14 years old
  • Individuals assigned moderate to high risk to reoffend as determined upon entrance to the Minnesota Correctional System by the DOC Risk Assessment/Community Notification Unit."

Exclusion Criteria:

  • Diagnosed with an active, uncontrolled major mental disorder (e.g. bi-polar, schizophrenia, schizoaffective disorder, major depression with psychotic features)
  • Unable to read English at the 5th grade level
  • Unable to speak English
  • IQ of less than 85 as measured by standard intelligence tests
  • Diagnosis of intellectual disability
  • Engaged in violent behavior while incarcerated, as indicated by disciplinary actions and/or segregation within 60 days of intake"

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention arm
32-week group therapy
32 weeks of group therapy
Active Comparator: Control group
Treatment as Usual
Control participants remain in their current placement and may be eligible for a number of services offered to inmates to facilitate rehabilitation and planning for release to the community, including sexual offender treatment. MnDOC's sexual offender treatment is a two to three year program, thus most of our control subjects will not have enough time remaining on their sentences to complete such treatment. However, a number of them may participate in MnDOC's current program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Violence Risk Scale-Sexual Offense Version (VRS:SO)
Time Frame: 7 days post-intervention
Clinician rating scale. 24-items measuring likelihood of sexual offense recidivism using a 4 point scale.
7 days post-intervention
Coping Using Sex Inventory (CUSI)
Time Frame: 7 days post-intervention
Self-report scale. 16 items measuring consensual, non-consensual, and child-focused sexual coping strategies using a 5-point scale
7 days post-intervention
Compulsive Sexual Behavior Inventory-13 (CSBI-13)
Time Frame: 7-days post-intervention
Self-report scale. 13 item scale measuring the presence of compulsive sexual behaviors on a 5- point scale.
7-days post-intervention
Types of Jealousy Scale (3 subscales; reactive, preventive, and anxious jealousy)
Time Frame: 7 days post-intervention
Self-report scale. 15 items measuring the intensity of reactive jealousy, experience and use of preventive jealousy, and frequency of anxious jealousy on a 5-point scale.
7 days post-intervention
Faith in People Scale
Time Frame: 7 days post-intervention
Self-report scale. 5 item scale measuring attitudes toward human nature. Two forced- choice items and three agreement/disagreement items.
7 days post-intervention
Trust in People Scale (Survey Research Center)
Time Frame: 7 days post-intervention
Self-report scale. 3 item scale measuring perception of general trustworthiness of others.
7 days post-intervention
Aggression Questionnaire (AQ; Buss &) - Physical Aggression, Verbal Aggression, and Anger Subscales ONLY
Time Frame: 7 days post-intervention
Self-report scale. 21 items throughout the 3 subscales measuring how characteristic physical aggression, verbal aggression, and anger-related behaviors are for respondents on a 7 point scale.
7 days post-intervention
Revised UCLA Loneliness Scale (R-UCLA)
Time Frame: 7 days post-intervention
Self-report scale. 20 items measuring subjective feelings of loneliness and social isolation on a 4 point scale.
7 days post-intervention
Self-Critical Rumination Scale (SCRS)
Time Frame: 7 days post-intervention
Self-report scale. 10 items measuring self- criticism on a 4 point scale.
7 days post-intervention
External/Internal Shame Scale - Sense of Isolation/Exclusion Subscale ONLY (EISS)
Time Frame: 7 days post-intervention
Self-report scale. Measures perceived sense of exclusion and being isolated or misunderstood by people on a 5 point scale.
7 days post-intervention
Children and Sex Questionnaire Emotional Congruence Scale (CSQ:ECWC)
Time Frame: 7 days post-intervention
Self-report scale. 15 item scale measuring emotional congruence with children on a 5 point scale.
7 days post-intervention
The Openness to Men and Women Scales (OPM, OPWO)
Time Frame: 7 days post-intervention
Self-report scale. 18 items assessing openness to intimacy with women and men on a 4 point scale.
7 days post-intervention
Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)
Time Frame: 7 days post-intervention
Self-report scale. 18 items measuring problems with emotion regulation including subscales for strategies, non-acceptance, impulse, goals, awareness, and clarity on a 5 point scale.
7 days post-intervention
Coping Strategy Indicator (CSI)
Time Frame: 7 days post-intervention
Self-report scale. 33 items measuring adaptive and maladaptive coping strategies (avoidance, problem-solving, social support seeking) on a 3 point scale.
7 days post-intervention
Aggression Inventory (AI)- Impulsive, Impatient, and Avoid subscales ONLY
Time Frame: 7 days post-intervention
Self-report scale. 22 item scale measuring perceptions and use of aggressive behaviors for men a women on a 5 point scale.
7 days post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Group Climate Questionnaire - Short Form (GCQ-5)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 12 items measuring group perceptions of the group therapeutic environment on a 7 point scale.
Every 14 days for first two months, than every four weeks for next four months
Curative Climate Instrument (CCI)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 14 items measuring specific change processes perceived as helpful to individual group members (catharsis, insight, and cohesiveness) on a 5 point scale.
Every 14 days for first two months, than every four weeks for next four months
Treatment Motivation Questionnaire-Revised (TMQ-R)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 23 items measuring internal and external reasons for participating in treatment, motivations relating to connecting and sharing with others, and clients' potential lack of confidence in treatment on a 7 point scale.
Every 14 days for first two months, than every four weeks for next four months
Therapeutic Agency Inventory (TAI)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 15 items measuring clients' experience of agency in making positive change and ability to take an active role in their therapy on a 5 point scale.
Every 14 days for first two months, than every four weeks for next four months
Relationship Questionnaire (RQ)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 4 items measuring adult attachment style on a 7 point scale.
Every 14 days for first two months, than every four weeks for next four months
Working Alliance Inventory - Short Form (WAI- SR)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
Self-report scale. 12 items measuring three domains of the therapeutic alliance: goals, tasks, and bond on a 5 point scale.
Every 14 days for first two months, than every four weeks for next four months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Miner, Ph.D, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2024

Primary Completion (Actual)

May 14, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

October 16, 2023

First Submitted That Met QC Criteria

November 6, 2023

First Posted (Actual)

November 13, 2023

Study Record Updates

Last Update Posted (Actual)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FMCH-2023-32331

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Sexual Abuse

Clinical Trials on group therapy

Subscribe